FDA Issues Pooling and Serial Testing Amendment for Certain SARS-CoV-2 Tests.
| Publicado en: | Clinical Laboratory News Vol. 47; no. 5; pp. 28 - 30 |
|---|---|
| Formato: | pictorial Journal Article |
| Publicado: |
American Association for Clinical Chemistry
Jun2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=151116556&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 151116556 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 01619640 IT4V jtl: Clinical Laboratory News issn: 01619640 maglogo: N pubinfo: dt: Jun2021 vid: 47 iid: 5 pid: 97416 pub: American Association for Clinical Chemistry place: Washington, District of Columbia artinfo: ui: 151116556 151116556 151116556 151116556 ppf: 28 ppct: 2 formats: fmt: @attributes: type: P tig: atl: FDA Issues Pooling and Serial Testing Amendment for Certain SARS-CoV-2 Tests. aug: sug: subj: United States Food and Drug Administration COVID-19 Testing Coronavirus Infections Diagnosis Health Screening Specimen Handling Documentation pubtype: Academic Journal doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|